Pregnancy loss

The Boston Globe Names Inkhouse a 2022 Top Place to Work

Retrieved on: 
Thursday, December 1, 2022
Professional Services, Other Communications, Public Relations, Investor Relations, Small Business, Marketing, Advertising, Communications, DEI (Diversity, Equity and Inclusion), Digital Marketing, Human Resources, Content Marketing, Culture, Boston.com, DE, BGMP, STAT, Work, A-side and B-side, Multimedia, Trial balance, Policy, Workforce, City, News, Pregnancy loss, Leave of absence, Woman, PR, Management

Inkhouse , a strategic communications firm, has been named one of the Top Places to Work in Massachusetts in the 15th annual employee-based survey from The Boston Globe.

Key Points: 
  • Inkhouse , a strategic communications firm, has been named one of the Top Places to Work in Massachusetts in the 15th annual employee-based survey from The Boston Globe.
  • Its an honor to be named a Top Place to Work by The Boston Globe for the fourth time, and it's a testament to the extraordinarily kind, values-based work community that weve built together.
  • About Boston Globe Media Partners, LLC
    Boston Globe Media Partners, LLC ("BGMP") is a multimedia organization that provides news, entertainment, and commentary across multiple brands and platforms.
  • BGMP properties include The Boston Globe, Globe Opinion, Globe.com, Boston.com, STAT, The B-Side, Globe Publishing Services, Globe Events, and Studio/B.

Inkhouse Promotes Five Senior Leaders Capping off a Record Year of Growth

Retrieved on: 
Thursday, November 17, 2022
Marketing, Advertising, Communications, Social Media, Search Engine Marketing, Public Relations, Investor Relations, Marketing, Research Triangle, Lead, Multimedia, Social media, Leave of absence, Culture, Mentorship, Growth, Pregnancy loss, PR, City, Media strategy, Journalism, Video game

He will also help Inkhouse operationalize its growing portfolio of digital content services including social media marketing which make up 10 percent of the firms revenue.

Key Points: 
  • He will also help Inkhouse operationalize its growing portfolio of digital content services including social media marketing which make up 10 percent of the firms revenue.
  • OMahony joined Inkhouse in 2014 as a vice president in the firms San Francisco office before eventually becoming general manager, California.
  • The newly promoted senior leaders, on average, have worked at Inkhouse for at least nine years which illustrates the firms strong employee retention rate and commitment to workplace culture .
  • Inkhouse is a strategic communications firm for innovative thinkers, creators and leaders who believe in the power of stories to effect positive change.

Bionano Genomics Reports Third Quarter 2022 Financial Results and Highlights Recent Business Progress

Retrieved on: 
Thursday, November 3, 2022
Chronic lymphocytic leukemia, DNA, Society, Potency (pharmacology), IPSC, Cerebellar ataxia, BMA, Regenerative medicine, MD Anderson Cancer Center, Schizophrenia, CRISPR, Company, Infertility, Workflow, Study, Growth, SAN, GAAP, OGM, GLOBE, Total, Ataxia, Genomics, LDT, ASHG, Chromothripsis, Patient, Cancer, CLL, Doctor of Philosophy, MDS, Long, SVS, Research, Hospital, Human genetics, Lineagen, Sale, International Cancer Genome Consortium, Pregnancy loss, NIPT, CTH, Adoption, Long-string instrument, UHMW, American Society of Human Genetics, Chromosome, ATM, RPL, Industry, Microdeletion syndrome, Publication, Certification, Tumors of the hematopoietic and lymphoid tissues, Acute myeloid leukemia, Nasdaq, Peripheral neuropathy, Karyotype, TP53, AML, RFC1, Renewable energy, Video game, Pharmaceutical industry, Medical imaging

SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today reported financial results for the third quarter ended September 30, 2022.

Key Points: 
  • milestones
    Strong balance sheet with $180.2 million in cash, cash equivalents, and available-for-sale securities at the end of Q3 2022
    SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today reported financial results for the third quarter ended September30, 2022.
  • We believe our Q3 2022 results, which include the highest quarterly revenues ever for Bionano, reflect continued gains in market development and commercial validation for OGM.
  • Total revenue for Q3 2022 was $7.2 million, up 55% from Q3 2021, and an 8% increase from Q2 2022.
  • Chris Stewart, chief financial officer of Bionano added, Q3 2022 was another outstanding quarter for Bionano.

Ovation Fertility Licenses Genomic Prediction’s LifeView PGT Platform

Retrieved on: 
Friday, October 21, 2022
Physician, Method, Risk, Life, Science, Laboratory, Parent, Family, Patient, Aneuploidy, Degenerative disease, Mosaic, Chromosome, Lists of diseases, Partnership, Cancer, NGS, Egg, IVF, Diabetes, Fertility, Genetic testing, Pregnancy loss, GLOBE, Infertility, Child, PGT, Pregnancy, Vaccine, Birth control, Mineral oil, Pharmaceutical industry, MD

By licensing the companys LifeViewTM PGT platform for use in Ovation Genetics labs, Ovation will be able to offer physicians and patients the most comprehensive preimplantation genetic testing (PGT) available to aid in the selection of optimal-quality embryos for transfer as part of IVF.

Key Points: 
  • By licensing the companys LifeViewTM PGT platform for use in Ovation Genetics labs, Ovation will be able to offer physicians and patients the most comprehensive preimplantation genetic testing (PGT) available to aid in the selection of optimal-quality embryos for transfer as part of IVF.
  • With five LifeView PGT options, Ovation will enhance and expand its PGT capabilities to provide even better outcomes for physicians and patients.
  • Ovation Fertility is pleased to partner with Genomic Prediction to expand the availability of the LifeView platform to Ovations genetic testing clients.
  • Learn more about Genomic Prediction's LifeView PGT testing at www.lifeview.com.

OGM Evaluated as a Method for Investigating Abnormal NIPT Results due to its Ability to Detect Chromosomal Structural Variations Found in Recurrent Pregnancy Loss

Retrieved on: 
Friday, October 14, 2022
Adoption, Non-functional testing, Genetic counseling, SAN, U.S. Securities and Exchange Commission, OGM, KT, Autism, Risk, Medicine, NIPT, Annual report, CMA, Patient, Lineagen, Biology, Hospital Insurance and Diagnostic Services Act, Research, Security (finance), Nasdaq, Private Securities Litigation Reform Act, Software, Amniocentesis, Company, Doctor of Philosophy, Karyotype, Chromosomal rearrangement, CCR, Genomics, Pregnancy loss, GLOBE, Infertility, Genome, Forward-looking statement, Chromosome, Pregnancy, COVID-19, Solution, Medical imaging

The study sought to determine OGMs utility for detection of chromosome breakages and fusions found in complex chromosomal rearrangements (CCR), which can significantly increase an abnormal pregnancy outcome for carrier couples.

Key Points: 
  • The study sought to determine OGMs utility for detection of chromosome breakages and fusions found in complex chromosomal rearrangements (CCR), which can significantly increase an abnormal pregnancy outcome for carrier couples.
  • The researchers used OGM as part of a confirmatory workflow after amniocentesis, karyotyping (KT), and chromosomal microarray analysis (CMA) identified suspected structural rearrangements with unknown origins, believed to indicate a CCR event.
  • We believe OGM could be used as a comprehensive follow-up genome analysis in cases with a positive NIPT screen or for some high-risk pregnancies.
  • The Companys mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.

AHN Perinatal Palliative Care Program Recognizes October as National Pregnancy and Infant Loss Awareness Month

Retrieved on: 
Thursday, October 13, 2022
Statistics, Physician, Emotion, National Association Medical Staff Services, Caregiver, Time, Allegheny Health Network, Pregnancy and Infant Loss Remembrance Day, Mare reproductive loss syndrome, Organ transplantation, Mental health, Cardiovascular disease, Culture, Network, Infant, Obstetrics, Woman, Diagnosis, Autoimmune disease, Father, Family, Parent, Organization, Mother, National, Patient, Hospital, Osteopathic medicine in the United States, Research, Man, Program, Drexel University College of Medicine, Friends, Lake Erie College, Palliative care, Miscarriage, MD, Health, Neurology, Neurosurgery, Pain, Social media, Diabetes, Pregnancy loss, ACOG, Child, Grief, AHN, American College, Pregnancy, Lake Erie College of Osteopathic Medicine, Birth control, Medicine, General store, Gynaecology

PITTSBURGH, Oct. 13, 2022 /PRNewswire-PRWeb/ -- Allegheny Health Network's (AHN) Perinatal Palliative Care program, "Olivia's Angels," will recognize this month as National Pregnancy and Infant Loss Awareness Month by sharing helpful guidance and resources for grieving parents as well as their friends, family and loved ones.

Key Points: 
  • PITTSBURGH, Oct. 13, 2022 /PRNewswire-PRWeb/ -- Allegheny Health Network's (AHN) Perinatal Palliative Care program, "Olivia's Angels," will recognize this month as National Pregnancy and Infant Loss Awareness Month by sharing helpful guidance and resources for grieving parents as well as their friends, family and loved ones.
  • Olivia's Angels is the most comprehensive perinatal hospice and miscarriage support program in the region.
  • Through the program, a team of AHN physicians and caregivers support and care for patients who have experienced a sudden perinatal loss or receive a diagnosis that their child's life will be limited.
  • In addition to clinical guidance, the team provides extra palliative care, hospice and bereavement care for families.

Award-Winning Fertility Doctor Joins Reproductive Specialists of the Carolinas

Retrieved on: 
Tuesday, October 11, 2022
REI, Reproduction, Obstetrics, Brown, Gynaecology, Reproductive medicine, Patient, IUI, Anovulation, Baylor University, University, Fibroid, Society, Healthcare disparity in Massachusetts, IVF, Pregnancy loss, RSC, Baylor College of Medicine, Fertility preservation, Medical device, Infertility, Science

CHARLOTTE, N.C., October 11, 2022 /PRNewswire-PRWeb/ -- Reproductive Specialists of the Carolinas ("RSC") is pleased to announce that Dr. Luwam Ghidei, an award-winning reproductive endocrinologist and infertility specialist, has joined the boutique fertility practice, making it possible for even more patients to receive advanced and inclusive reproductive care.

Key Points: 
  • Dr. Luwam Ghidei has joined founder Dr. Matrika Johnson and the RSC staff to further enhance the personalized fertility care for patients throughout the Carolinas.
  • CHARLOTTE, N.C., October 11, 2022 /PRNewswire-PRWeb/ -- Reproductive Specialists of the Carolinas ("RSC") is pleased to announce that Dr. Luwam Ghidei, an award-winning reproductive endocrinologist and infertility specialist, has joined the boutique fertility practice, making it possible for even more patients to receive advanced and inclusive reproductive care.
  • Reproductive Specialists of the Carolinas is located at 1918 Randolph Rd, Ste 410, Charlotte, NC 28207-1109.
  • Dr. Matrika Johnson, Reproductive Specialists of the Carolinas, +1 704.247.2209, [email protected]

Acubalance Wellness Centre Proud Sponsor of Vancouver's Butterfly Run October 1st

Retrieved on: 
Saturday, October 1, 2022
Pregnancy and Infant Loss Remembrance Day, Pregnancy loss, Woman, Risk, Infant, Infertility, Acupuncture, Pregnancy, Fertility, Alternative, Miscarriage, Anxiety, Family, Butterfly, Awareness, Walkers, LLLT, Depression, Birth control

VANCOUVER, B.C., Sept. 30, 2022 /PRNewswire-PRWeb/ -- October is pregnancy and infant loss awareness month with the Butterfly Run kicking off the month on October 1st with a 5 km and 3 km run/walk to raise awareness about these often-silent losses. The run raises funds to help support those who have experienced infertility, pregnancy loss, and infant loss. The Butterfly Run was founded by families who experienced miscarriage or infant death and wanted to bring awareness and support to those that may be grieving in the shadows and share the message, "you are not alone."

Key Points: 
  • The Butterfly Run kicks off pregnancy and infant loss awareness month on October 1st with a 5 km and 3 km run/walk in Vancouver and Victoria.
  • The run raises funds to help support those who have experienced infertility, pregnancy loss, and infant loss.
  • At Acubalance Wellness Centre, we have an integrative approach to treating miscarriages and implantation failure.
  • Acubalance Wellness Centre is a proud sponsor of the Butterfly Run and will be running a team in the Vancouver run and will be providing healthy snacks and light massages for walkers and runners.

Bionano Genomics Announces Publication of Study Using OGM for Detection of Balanced Chromosomal Rearrangements Found in Recurrent Pregnancy Loss

Retrieved on: 
Wednesday, September 21, 2022
Software, Adoption, RPL, Child, Pregnancy loss, COVID-19, Fluorescence, Risk, Infertility, Company, Private Securities Litigation Reform Act, Forward-looking statement, U.S. Securities and Exchange Commission, Patient, Lineagen, History, OGM, FISH, Biology, Genetic testing, In situ hybridization, Nasdaq, Miscarriage, Solution, Annual report, Doctor of Philosophy, Autism, Genomics, SAN, Research, Security (finance), GLOBE, Medicine, Genome, Birth, Hospital Insurance and Diagnostic Services Act, Fetus, Medical imaging, Risk management

SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study utilizing OGM to detect cryptic balanced chromosomal rearrangements (BCRs) found in subjects who experienced recurrent pregnancy loss (RPL).

Key Points: 
  • SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study utilizing OGM to detect cryptic balanced chromosomal rearrangements (BCRs) found in subjects who experienced recurrent pregnancy loss (RPL).
  • Compared to traditional cytogenetic methods, OGM successfully identified cryptic reciprocal translocation in all samples, improving the success rate for finding pathogenic variants of cryptic BCRs and streamlining the process of detection.
  • Erik Holmlin, PhD, president and chief executive officer of Bionano commented, This study shows support for OGM in an area that we believe may prove to be very helpful to people struggling with infertility and pregnancy loss.
  • The Companys mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.

The Diversity Marketing Consortium™ Adds Two New Agencies to its Roster

Retrieved on: 
Tuesday, August 16, 2022
Digital Marketing, Social Media, Search Engine Optimization, Search Engine Marketing, Public Relations, Investor Relations, Marketing, Advertising, Communications, Woman, Partner (business rank), City, Leave of absence, Face, POC, Marketing, PR, DMC, Awareness, Diversity, Superbolt, Culture, Pregnancy loss, Organization, Property management, Cryptocurrency, Public relations

Today, the Diversity Marketing Consortium (DMC) announced the addition of two new agency partners to its roster Inkhouse and No.

Key Points: 
  • Today, the Diversity Marketing Consortium (DMC) announced the addition of two new agency partners to its roster Inkhouse and No.
  • 29 join the DMCs existing group of agencies SourceCode Communications , Superbolt , Cheer Partners , Peppercomm , Clarity , Racepoint Global , Praytell and Max Borges Agency .
  • Founded in 2020, the Diversity Marketing Consortium was formed in an effort to help offset systemic racial and gender-based inequity for women and minority founders.
  • The Diversity Marketing Consortiums mission is to help level the playing field for underrepresented founders by providing pro bono marketing services.